Industry News
Pharmaceutical Industry News
J&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn’s data
J&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn's data fkansteiner Fri, 02/18/2022 - 07:52
Fierce Pharma Asia—Lilly, Innovent’s I-O implications; Novartis’ India job cuts; Moderna’s Asia expansion
Fierce Pharma Asia—Lilly, Innovent's I-O implications; Novartis' India job cuts; Moderna's Asia expansion aliu Fri, 02/18/2022 - 06:45
Este no es el fin de la pandemia del coronavirus. Veamos lo que pasó con el sida
Todos queremos volver a la normalidad y declarar el fin del peligro de la COVID-19. Pero eso no es cierto para una buena parte del mundo.
Agios’ first-in-class PK activator Pyrukynd scores FDA approval to treat rare blood disorder
Agios' first-in-class PK activator Pyrukynd scores FDA approval to treat rare blood disorder esagonowsky Thu, 02/17/2022 - 16:45
Organon CEO pins high hopes on upcoming Humira biosimilar launch
Organon CEO pins high hopes on upcoming Humira biosimilar launch fkansteiner Thu, 02/17/2022 - 13:05
Bayer hikes Nubeqa’s peak sales to more than €3B on prostate cancer data, teeing up new 3-way battle against Pfizer-Astellas, J&J
Bayer hikes Nubeqa's peak sales to more than €3B on prostate cancer data, teeing up new 3-way battle against Pfizer-Astellas, J&J aliu Thu, 02/17/2022 - 12:22
The Moral Danger of Declaring the Pandemic Over Too Soon
There has to be a better way out of the rubble of the past two years.
GSK launches trade secrets case against former employee, ordering data and property to be returned ‘in one piece’
GSK launches trade secrets case against former employee, ordering data and property to be returned 'in one piece' fkansteiner Thu, 02/17/2022 - 11:02
Teva takes ‘skinny’ label dispute with GlaxoSmithKline to the Supreme Court: reports
Teva takes 'skinny' label dispute with GlaxoSmithKline to the Supreme Court: reports fkansteiner Thu, 02/17/2022 - 09:40
Bristol Myers scores FDA priority review in high-stakes expansion bid for CAR-T drug Breyanzi
Bristol Myers scores FDA priority review in high-stakes expansion bid for CAR-T drug Breyanzi kdunleavy Thu, 02/17/2022 - 09:34
Eli Lilly, with latest Verzenio nod, teams up with a host of breast cancer groups for new education campaign
Eli Lilly, with latest Verzenio nod, teams up with a host of breast cancer groups for new education campaign badams Thu, 02/17/2022 - 08:28
Women’s telehealth startup Alloy turns up the heat on men to bring attention to menopause symptoms
Women's telehealth startup Alloy turns up the heat on men to bring attention to menopause symptoms nmissakian Thu, 02/17/2022 - 08:13
Moderna, Rovi ink 10-year contract extension for production of COVID and future vaccines
Moderna, Rovi ink 10-year contract extension for production of COVID and future vaccines jkeenan Thu, 02/17/2022 - 07:47
Moderna swings into expansion mode, adding 6 European countries to its commercial empire
Moderna swings into expansion mode, adding 6 European countries to its commercial empire aliu Thu, 02/17/2022 - 06:38
Eliquis partners BMS, Pfizer double down on heart health with renewed ‘No Time to Wait’ campaign
Eliquis partners BMS, Pfizer double down on heart health with renewed ‘No Time to Wait’ campaign badams Thu, 02/17/2022 - 04:56
Argenx’s Vygart launch finds quick neurologist support over AstraZeneca’s well-entrenched Soliris for myasthenia gravis
Argenx's Vygart launch finds quick neurologist support over AstraZeneca's well-entrenched Soliris for myasthenia gravis badams Thu, 02/17/2022 - 04:37
Argenx’s Vyvgart launch finds quick neurologist support over AstraZeneca’s well-entrenched Soliris for myasthenia gravis
Argenx's Vyvgart launch finds quick neurologist support over AstraZeneca's well-entrenched Soliris for myasthenia gravis badams Thu, 02/17/2022 - 04:37
3 more deaths among patients on Biogen’s Aduhelm fuel safety concerns, though no link established: analyst
3 more deaths among patients on Biogen's Aduhelm fuel safety concerns, though no link established: analyst kdunleavy Wed, 02/16/2022 - 18:15
Lilly’s tirzepatide doesn’t necessarily top diabetes rivals Jardiance and Ozempic, ICER says
Lilly's tirzepatide doesn't necessarily top diabetes rivals Jardiance and Ozempic, ICER says fkansteiner Wed, 02/16/2022 - 11:57
As Johnson & Johnson fights for bankruptcy ploy in talc litigation, Congress is weighing in
As Johnson & Johnson fights for bankruptcy ploy in talc litigation, Congress is weighing in kdunleavy Wed, 02/16/2022 - 11:36